CHADS2 score is associated with 3-month clinical outcomes after intravenous rt-PA therapy in stroke patients with atrial fibrillation: SAMURAI rt-PA Registry
- 15 July 2011
- journal article
- Published by Elsevier BV in Journal of the Neurological Sciences
- Vol. 306 (1-2), 49-53
- https://doi.org/10.1016/j.jns.2011.03.046
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Survival after stroke — The impact of CHADS2 score and atrial fibrillationInternational Journal of Cardiology, 2010
- Arterial Occlusion Sites on Magnetic Resonance Angiography Influence the Efficacy of Intravenous Low-Dose (0·6 mg/kg) Alteplase Therapy for Ischaemic StrokeInternational Journal of Stroke, 2009
- Routine Use of Intravenous Low-Dose Recombinant Tissue Plasminogen Activator in Japanese PatientsStroke, 2009
- Stroke risk in atrial fibrillation patients on warfarinThrombosis and Haemostasis, 2009
- Multivariable Analysis of Outcome Predictors and Adjustment of Main Outcome Results to Baseline Data Profile in Randomized Controlled TrialsStroke, 2008
- Large Ischemic Lesions on Diffusion-Weighted Imaging Done Before Intravenous Tissue Plasminogen Activator Thrombolysis Predicts a Poor Outcome in Patients With Acute StrokeStroke, 2008
- Risks and Benefits of Oral Anticoagulation Compared With Clopidogrel Plus Aspirin in Patients With Atrial Fibrillation According to Stroke RiskStroke, 2008
- Major Hemorrhage and Tolerability of Warfarin in the First Year of Therapy Among Elderly Patients With Atrial FibrillationCirculation, 2007
- Selecting Patients With Atrial Fibrillation for AnticoagulationCirculation, 2004
- Validation of Clinical Classification Schemes for Predicting StrokeJAMA, 2001